Tumor initiation and progression are the outcomes of a stepwise accumulation of genetic alterations. Among these, gene amplification and aberrant expression of oncogenic proteins, as well as deletion or inactivation of tumor suppressor genes, represent hallmark steps. Mounting evidence collected over the last few years has identified different populations of non-coding RNAs as major players in tumor suppression in almost all cancer types. Elucidating the diverse molecular mechanisms underlying the roles of non-coding RNAs in tumor progression might provide illuminating insights, potentially able to assist improved diagnosis, better staging and effective treatments of human cancers. Here we focus on several groups of tumor suppressor microRNAs, whose downregulation exerts a profound oncologic impact and might be harnessed for the benefit of cancer patients.

Tumor suppressor microRNAs : a novel non-coding alliance against cancer / G. Blandino, F. Fazi, S. Donzelli, M. Kedmi, A. Sas-Chen, P. Muti, S. Strano, Y. Yarden. - In: FEBS LETTERS. - ISSN 0014-5793. - 588:16(2014), pp. 2639-2652.

Tumor suppressor microRNAs : a novel non-coding alliance against cancer

P. Muti
Conceptualization
;
2014

Abstract

Tumor initiation and progression are the outcomes of a stepwise accumulation of genetic alterations. Among these, gene amplification and aberrant expression of oncogenic proteins, as well as deletion or inactivation of tumor suppressor genes, represent hallmark steps. Mounting evidence collected over the last few years has identified different populations of non-coding RNAs as major players in tumor suppression in almost all cancer types. Elucidating the diverse molecular mechanisms underlying the roles of non-coding RNAs in tumor progression might provide illuminating insights, potentially able to assist improved diagnosis, better staging and effective treatments of human cancers. Here we focus on several groups of tumor suppressor microRNAs, whose downregulation exerts a profound oncologic impact and might be harnessed for the benefit of cancer patients.
Cancer; Tumor suppressor microRNAs; Animals; Humans; MicroRNAs; Neoplasms; Genes, Tumor Suppressor
Settore BIO/12 - Biochimica Clinica e Biologia Molecolare Clinica
2014
Article (author)
File in questo prodotto:
File Dimensione Formato  
Copia di blandino et al.pdf

accesso aperto

Tipologia: Pre-print (manoscritto inviato all'editore)
Dimensione 363.02 kB
Formato Adobe PDF
363.02 kB Adobe PDF Visualizza/Apri
Blandino_et_al-2014-FEBS_Letters.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 1.64 MB
Formato Adobe PDF
1.64 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/663815
Citazioni
  • ???jsp.display-item.citation.pmc??? 35
  • Scopus 64
  • ???jsp.display-item.citation.isi??? 54
social impact